Aruna Pradhan
CCVDP & The Brigham and Women's Hospital · Brigham and Women's Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Aruna Pradhan as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:54 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT03071692 · Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)Kowa Research Institute, Inc. · terminated · Type2 Diabetes, Dyslipidemia · study director
- Ph3NCT01633177 · Study of Vitamin D and Omega-3 Supplementation for Preventing DiabetesBrigham and Women's Hospital · completed · Type 2 Diabetes · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Anti-inflammatory Therapy with Low Dose Methotrexate for Reduction of PADR01HL122158 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2014 to 2017 · $355,000 awarded in 2017Same name and institution; not confirmed by an ID
- Diabetes Prevention in the Vitamin D and Omega-3 TrialR01DK088078 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2013 to 2014 · $435,185 awarded in 2014Grant number is on one of their registry trials
- Mechanisms of Statin-Induced DM in JUPITER (Rosuvasatin for CVD Prevention)R01HL103742 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2010 to 2013 · $237,768 awarded in 2013Same name and institution; not confirmed by an ID
- Novel and Traditional Risk Factors for Symptomatic PAD in WomenK08HL082740 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2006 to 2010 · $136,350 awarded in 2010Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:54 UTC. The ranking covers the 200 most relevant of 52 PubMed records, and a shared surname and initials can bring in a namesake. All 52 on PubMed
- 3,304 citationsRCR 81.4
- Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.N Engl J Med · 20191,061 citationsRCR 45.0
- 639 citationsRCR 19.4
- Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.N Engl J Med · 2022618 citationsRCR 50.5
- 578 citationsRCR 59.9
- Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis.Am Heart J · 2013300 citationsRCR 8.7
- Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease.J Am Coll Cardiol · 2020283 citationsRCR 14.8
- Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes.J Am Coll Cardiol · 2018279 citationsRCR 10.0
- 210 citationsRCR 7.5
- Adverse Effects of Low-Dose Methotrexate: A Randomized Trial.Ann Intern Med · 2020175 citationsRCR 10.1